Apple
AAPL
Taylor Morrison Home
TMHC
D.R. Horton
DHI
4
Petroleo Brasileiro SA Petrobras
PBR
5
Vale SA
VALE
US Stock MarketDetailed Quotes
IMCR Immunocore
- 30.130
- +0.660+2.24%
Close Mar 27 16:00 ET
- 29.980
- -0.150-0.50%
Pre 04:38 ET
1.51BMarket Cap-29.54P/E (TTM)
30.340High28.920Low555.27KVolume29.030Open29.470Pre Close16.62MTurnover1.60%Turnover RatioLossP/E (Static)50.07MShares66.00052wk High4.18P/B1.05BFloat Cap27.19052wk Low--Dividend TTM34.69MShs Float76.980Historical High--Div YieldTTM4.82%Amplitude18.430Historical Low29.929Avg Price1Lot Size
About Immunocore Company
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolIMCR
Company NameImmunocore
Listing DateFeb 5, 2021
Issue Price26.00
Founded2021
CEODr. Bahija Jallal, PhD
MarketNASDAQ
Employees493
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address92 Park Drive,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RY
Phone44-1235-438600
Websitehttp://immunocore.com
Company Executives
- Name
- Position
- Salary
- Dr. Bahija Jallal, PhD
- Chief Executive Officer and Director
- 11.68M
- Tina St. Leger
- Chief Human Resources Officer
- 1.04M
- Travis Coy
- Executive Vice President, Chief Financial Officer and Head of Corporate Development
- --
- John Goll
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Professor Sir John Bell
- Chairman of the Board
- 416.99K
- Ranjeev Krishana
- Director
- --
- Dr. William Pao, M.D.,PhD
- Director
- --
- Professor Sir Peter Ratcliffe
- Independent Director
- 384.49K
- Kristine Peterson
- Independent Director
- 389.49K
- Siddharth Kaul
- Independent Director
- 386.99K
- Roy Steven Herbst, M.D.
- Independent Director
- 386.99K
- Robert J. Perez
- Independent Director
- --
- Dr. David Berman, M.D.
- Head of Research and Development
- 4.40M
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call